Eye pressure battle: which tiny implant wins for glaucoma?
NCT ID NCT07359547
Summary
This study compares two tiny, minimally invasive eye implants for adults with open-angle glaucoma that isn't controlled with eye drops alone. Researchers will randomly assign 166 participants to receive either the XEN-63 Gel Stent or the PRESERFLO MicroShunt during a single surgery. They'll follow participants for two years to see which device better lowers eye pressure, reduces the need for medications, and has fewer complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA 1, OPEN ANGLE, D (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ULS Santa Maria
NOT_YET_RECRUITINGLisbon, Lisbon District, 1649-028, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospitals UZ Leuven
RECRUITINGLeuven, Vlaams-brabant, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Bonn
RECRUITINGBonn, North Rhine-Westphalia, D-53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.